Loading...
Loading...
Holder clone rankings through .
Among the 1 tracked institutional investors we monitor, ERNAW (ERNEXA THERAPEUTICS INC) is held with a combined value of $5.07K across 160,000 shares. The largest holder is ARMISTICE CAPITAL, LLC with a position worth $5.07K.
Total Institutional Value
$5.07K
Total Shares Held
160,000
Institutional Holders
1
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | $5.07K | 0.00% | - |
As of the latest SEC 13F filings, ARMISTICE CAPITAL, LLC is the largest institutional holder of ERNAW with a position worth $5.07K, representing 0.00% of their portfolio. In total, 1 institutional investors hold ERNAW with a combined value of $5.07K.
Institutional investors hold $5.07K worth of ERNAW stock across 1 positions. The largest institutional holder is ARMISTICE CAPITAL, LLC with $5.07K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ERNAW, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
| — |
| 7.0% |
| 2026-10-30 |
SEC Schedule 13D (activist) and 13G (passive) filings for ERNAW. Filed when an investor acquires 5%+ ownership.
Last Close
$0.03
2026-11-18
YTD
-70.3%
5% of 52-week range